It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Macrophages are a heterogeneous population of mononuclear phagocytes abundantly distributed throughout the intestinal compartments that adapt to microenvironmental specific cues. In adult mice, the majority of intestinal macrophages exhibit a mature phenotype and are derived from blood monocytes. In the steady-state, replenishment of these cells is reduced in the absence of the chemokine receptor CCR2. Within the intestine of mice with colitis, there is a marked increase in the accumulation of immature macrophages that demonstrate an inflammatory phenotype. Here, we asked whether CCR2 is necessary for the development of colitis in mice lacking the receptor for IL10. We compared the development of intestinal inflammation in mice lacking IL10RA or both IL10RA and CCR2. The absence of CCR2 interfered with the accumulation of immature macrophages in IL10R-deficient mice, including a novel population of rounded submucosal Iba1+ cells, and reduced the severity of colitis in these mice. In contrast, the absence of CCR2 did not reduce the augmented inflammatory gene expression observed in mature intestinal macrophages isolated from mice lacking IL10RA. These data suggest that both newly recruited CCR2-dependent immature macrophages and CCR2-independent residual mature macrophages contribute to the development of intestinal inflammation observed in IL10R-deficient mice.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Zagazig University, Faculty of Veterinary Medicine, Department of Microbiology, Zagazig, Egypt (GRID:grid.31451.32) (ISNI:0000 0001 2158 2757)
2 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438)
3 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Morphic Therapeutic, Waltham, USA (GRID:grid.2515.3)
4 Beth Israel Deaconess Medical Center, Department of Pathology, Boston, USA (GRID:grid.239395.7) (ISNI:0000 0000 9011 8547)
5 US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, USA (GRID:grid.417587.8) (ISNI:0000 0001 2243 3366)
6 Zagazig University, Faculty of Veterinary Medicine, Department of Microbiology, Zagazig, Egypt (GRID:grid.31451.32) (ISNI:0000 0001 2158 2757)
7 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Brigham and Women’s Hospital, Division of Gastroenterology, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
8 Boston Children’s Hospital, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Boston Children’s Hospital, Division of Emergency Medicine, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438)